全球医疗食品增长机会

在全球医疗食品市场，相信医药製造商与医疗食品製造商之间的合作将增加增长机会。

按成分来看，蛋白质成分行业将在 2021 年占据大部分份额，达到 64.0%，因为它在伤病康復方面发挥着重要作用。此外，由于医生意识的提高和患者的医疗依从性提高，北美和欧洲将在 2021 年占食品配料和成品的大部分份额。支持这些地区市场增长的因素是老年人口的增长、慢性病的流行以及政策制定者对营养不良管理的日益关注。

在本报告中，我们调查了全球医疗食品市场、市场背景、对市场的各种影响因素分析、法律法规和报销环境、按成分和用途划分的医疗食品的重要性、收益和销售趋势。它包括预测、分部和地区细分以及增长机会分析。

内容

战略要务

• 为什么增长越来越难
• 战略要务 8(TM)
• 三大战略要务的行业影响
• 推动增长管道引擎 (TM) 的增长机会

增长机会分析

• 分析范围
• 医疗食品的定义
• 营养补充剂、医疗食品和药品之间的区别
• 分类
• 定义：按成分
• 定义：按管理类型/模式
• 定义：按用途
• 主要公司
• 价值链
• 驱动程序
• 增长抑制
• 预测假设
• COVID-19：对医疗食品市场的影响
• COVID-19：触发调查
• 受 COVID-19 影响的市场趋势
• 监管状况
• 监管状态：北美
• 监管状态：欧洲
• 监管格局：亚太地区
• 保险范围和报销方案

增长机会分析：医疗膳食成分

• 成长指数
• 成分在患者康復中的作用：蛋白质成分
• 成分在患者康復中的作用：营养脂质
• 成分在患者康復中的作用：益生元
• 成分在患者康復中的作用：维生素和矿物质
• 成分趋势
• 收入预测
• 利润预测：按组件分类
• 利润预测分析：按组件
• 收入预测：按地区
• 收入预测分析：按地区
• 竞争环境
• 竞争对手产品矩阵
• 产品发布：医用食品配料

增长机会分析：完成医疗饮食

• 成长指数
• 处方药饮食示例
• 非处方药用食品示例
• 医学饮食的作用：营养不良
• 医疗食品的作用：代谢健康
• 医疗饮食的作用：消化系统健康
• 医学饮食的作用：重症监护和创伤
• 医学饮食的作用：肌肉骨骼健康
• 医疗饮食的作用：认知和中枢神经系统健康
• 医疗饮食的作用：糖尿病健康
• 医疗饮食的作用：心血管健康
• 收入预测
• 收入预测分析
• 收入预测：按类型
• 收入预测分析：按类型
• 收入预测：按管理模式
• 收入预测分析：按管理模式
• 收入预测：按地区
• 收入预测分析：按地区
• 收入率/市场渗透率：按应用
• 竞争环境
• 收入分成
• 近期收购
• 近期产品发布

增长机会领域

• 增长机会：医药製造商与医疗食品製造商之间的合作
• 增长机会：促销活动和广泛的报销范围
• 增长机会：医疗食品应用特定成分的设计研究更加关注
• 增长机会：功能材料的创新

下一步

Collaborative Efforts Between Drug Manufacturers and Medical Food Manufacturers to Boost Growth Opportunities for Medical Food

The US FDA defines medical food as "a food, which is formulated to be consumed or administered enterally under the supervision of a physician and which is intended for the specific dietary management of a disease or condition for which distinctive nutritional requirements, based on recognized scientific principles, are established by medical evaluation." Medical food is interpreted as 'food for special medical purposes (FSMPs)' in several countries, including Europe, India, China, and Australia and New Zealand. In Japan, medical food is interpreted as 'food for sick'. In Canada, medical food is governed by food for special dietary use (FSDU) and infant food regulations.

Globally, the regulatory landscape for medical food is not clearly defined, even in developed economies. As medical food is not intended to prevent or treat diseases, it is not subject to the same regulatory requirements as pharmaceutical drugs.

This Frost & Sullivan study aims to understand the role of medical food in patients' recovery. It provides qualitative and quantitative analyses of medical food ingredients and finished product medical food.

By ingredient, the medical food market is divided into vitamins and minerals; protein ingredients (animal and plant); nutritional lipids; prebiotics; and others (amino acids and probiotics). Of these, protein ingredients held the majority share of 64.0% (2021) in the total medical food ingredients market due to the important role they play in trauma and illness recovery.

Geographically, the study covers North America, Europe, Asia-Pacitfic, and Latin America and the Middle East and Africa (LAMEA). North America and Europe accounted for most of the market share for both medical food ingredients and finished product medical food in 2021 due to the rising physician awareness and the increasing medical adherence by patients. Factors supporting market growth in these regions are the expanding geriatric population, the prevalence of chronic diseases, and policymakers' growing emphasis on malnutrition management.

The impact of the COVID-19 pandemic is taken into account in the analysis. The pandemic induced both positive and negative changes in the medical food market. Supply chain disruptions due to the shutting down of processing facilities and other lockdown measures affected the sale of ingredients and finished medical food. However, the negaitve effects were reduced to some extent due to the growing consumer awareness and research highlighting the benefits of medical food in patients' recovery.

Key Features:

• By finished product, the medical food market is segmented by type, mode of administration, and application.

• By type, the medical food market is fragmented into prescription and nonprescription food. Prescription medical food dominated the medical food market with a 60.0% share in 2021 due to strong demand from developed economies for use in fatal health conditions such as oncology health, critical care and trauma, cardiovascular health, diabetes health, and cognitive health. Key market participants, such as Abbott, Nestle Health Science, and Nutricia, offer vast product portfolios of prescription medical food to meet the growing demand.

• By mode of administration, the medical food market is categorized into oral (food or supplement format) and enteral tube feeding. The oral mode accounted for the larger market share of 75.0% in 2021. Preference for orally administered products, ease of availability without prescriptions, and supportive initiatives are key factors driving demand for orally administered medical food.

• By application, the medical food market is segmented into malnutrition (including oncology health, immune health, and general malnutrition); metabolic health; digestive health; critical care and trauma; diabetes health; cardiovascular health; musculoskeletal health; and cognitive and central nervous system (CNS) health. Malnutrition, metabolic disorders, digestive disorders, and critical care and trauma are the top target diseases for medical food. Brain and cognitive health remains a small segment; nevertheless, it is one of the fastest-growing application areas for medical food.

Table of Contents

Strategic Imperatives

• Why is it Increasingly Difficult To Grow?
• The Strategic Imperative 8™
• The Impact of the Top 3 Strategic Imperatives on the Medical Food Industry
• Growth Opportunities Fuel The Growth Pipeline Engine™

Growth Opportunity Analysis

• Scope of Analysis
• Medical Food-Definition
• Differences between Dietary Supplements, Medical Food, and Pharmaceutical Drugs
• Segmentation
• Segmentation (continued)
• Definition by Ingredient Type
• Definition by Type and Mode of Administration
• Definition by Application
• Key Competitors
• Value Chain
• Growth Drivers
• Growth Restraints
• Forecast Assumptions
• Forecast Assumptions (continued)
• Impact of the COVID-19 Pandemic on the Medical Food Market
• COVID-19-Induced Research
• COVID-19-Induced Market Trends
• Regulatory Landscape
• Regulatory Landscape-North America
• Regulatory Landscape-Europe
• Regulatory Landscape-Asia-Pacific
• Regulatory Landscape-Asia-Pacific (continued)
• Insurance Coverage and Reimbursement Scenario
• Insurance Coverage and Reimbursement Scenario (continued)

Growth Opportunity Analysis-Medical Food Ingredients

• Growth Metrics
• Role of Ingredients in Patient Recovery-Protein Ingredients
• Role of Ingredients in Patient Recovery-Nutritional Lipids
• Role of Ingredients in Patient Recovery-Nutritional Lipids (continued)
• Role of Ingredients in Patient Recovery-Prebiotics
• Role of Ingredients in Patient Recovery-Vitamins and Minerals
• Role of Ingredients in Patient Recovery-Vitamins and Minerals (continued)
• Role of Ingredients in Patient Recovery-Vitamins and Minerals (continued)
• Ingredient Trends
• Ingredient Trends (continued)
• Ingredient Trends (continued)
• Revenue Forecast
• Revenue Forecast by Ingredient
• Revenue Forecast Analysis by Ingredients
• Revenue Forecast Analysis by Ingredients (continued)
• Revenue Forecast Analysis by Ingredients (continued)
• Revenue Forecast by Region
• Revenue Forecast Analysis by Region
• Revenue Forecast Analysis by Region (continued)
• Competitive Environment
• Competitive Product Matrix
• Product Launches-Medical Food Ingredients: 2021 and 2022
• Product Launches-Medical Food Ingredients: 2021
• Product Launches-Medical Food Ingredients: 2020 and 2022
• Product Launches-Medical Food Ingredients: 2019 and 2020

Growth Opportunity Analysis-Finished Product Medical Food

• Growth Metrics
• Prescription Medical Food-Examples
• Nonprescription Medical Food-Examples
• Role of Medical Food in Malnutrition Condition
• Role of Medical Food in Malnutrition Condition (continued)
• Role of Medical Food in Malnutrition Condition (continued)
• Role of Medical Food in Metabolic Health
• Role of Medical Food in Metabolic Health (continued)
• Role of Medical Food in Digestive Health
• Role of Medical Food in Critical Care and Trauma
• Role of Medical Food in Musculoskeletal Health
• Role of Medical Food in Cognitive and CNS Health
• Role of Medical Food in Diabetes Health
• Role of Medical Food in Cardiovascular Health
• Revenue Forecast
• Revenue Forecast Analysis
• Revenue Forecast Analysis (continued)
• Revenue Forecast by Type
• Revenue Forecast Analysis by Type
• Revenue Forecast by Mode of Administration
• Revenue Forecast Analysis by Mode of Administration
• Revenue Forecast Analysis by Mode of Administration (continued)
• Revenue Forecast by Region
• Revenue Forecast Analysis by Region
• Revenue Forecast Analysis by Region (continued)
• Revenue Forecast Analysis by Region (continued)
• Revenue Forecast Analysis by Region (continued)
• Revenue Forecast Analysis by Region (continued)
• Percent Revenue by Application and Market Penetration
• Competitive Environment
• Revenue Share
• Recent Acquisitions-2019-2022
• Recent Product Launches-2019, 2020, and 2021

Growth Opportunity Universe

• Growth Opportunity 1: Collaborative Efforts between Drug Manufacturers and Medical Food Manufacturers
• Growth Opportunity 1: Collaborative Efforts between Drug Manufacturers and Medical Food Manufacturers (continued)
• Growth Opportunity 2: Promotional Activities and Wide Reimbursement Coverage
• Growth Opportunity 2: Promotional Activities and Wide Reimbursement Coverage (continued)
• Growth Opportunity 3: Increased Research Focus on Designing Specific Ingredients for Medical Food Applications
• Growth Opportunity 3: Increased Research Focus on Designing Specific Ingredients for Medical Food Applications (continued)
• Growth Opportunity 4: Innovation in Functional Ingredients
• Growth Opportunity 4: Innovation in Functional Ingredients (continued)

Next Steps

• Your Next Steps
• Why Frost, Why Now?
• List of Exhibits
• List of Exhibits (continued)
• Legal Disclaimer